Zydus Cadila gets final nod from USFDA for Droxidopa Capsules
It is indicated for use in people with conditions of the nervous system that can cause low blood pressure
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Cadila
Zydus announces completion of Phase-I trials of ZY19489
ZY19489 has the potential to be a single-dose cure for P. falciparum and P. vivax malaria due to its novel mechanism of action,…
US FDA grants Orphan Drug Designation to Zydus’ Saroglitazar for primary biliary cholangitis…
This follows the grant of ‘Fast Track Designation’ by the USFDA to Saroglitazar Mg for PBC in December 2020
Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients:…
None of the hospitalised patients required mechanical ventilator in the Desidustat arm, while 25 per cent patients on the standard…
Zydus Cadila gets US FDA nod for Liothyronine Sodium Tablets
It is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism)
Four more COVID-19 vaccines in pipeline: Health Secretary
Zydus Cadila, Sputnik V, Biological E and Gennova are in advanced clinical trials in India, some of them likely to approach drug…
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D
The company will now be initiating Phase III clinical trial in around 30,000 volunteers
Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
Experts bat for global cooperation and coordination to tackle COVID-19 pandemic
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial…
ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company